Synergistic Effect of Colistin Combined with PFK-158 against Colistin-Resistant Enterobacteriaceae

As increasing numbers of colistin-resistant bacteria emerge, new therapies are urgently needed to treat infections caused by these pathogens. The discovery of new combination therapies is one important way to solve such problems. Here, we report that the antitumor drug PFK-158 and its analogs PFK-01...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Antimicrob Agents Chemother
Main Authors: Zhang, Youwen, Wang, Xiukun, Li, Xue, Dong, Limin, Hu, Xinxin, Nie, Tongying, Lu, Yun, Lu, Xi, Pang, Jing, Li, Guoqing, Yang, Xinyi, Li, Congran, You, Xuefu
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2019
נושאים:
Experimental Therapeutics
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6591609/
https://ncbi.nlm.nih.gov/pubmed/30988150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00271-19
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים